Abstract-Chronic
returned to the initial low level, together with the restitution of the initial low blood flow level, suggesting that PGI2 was responsible for the increase in CBF inherent in HLP.
Mongrel dogs of either sex weighing between 6-15 kg were anesthetized with sodium pentobarbital (35 mg/kg) adminis tered intraperitoneally. Heart-lung pre parations were prepared according to the Krayer-Mendez modifications of the original Starling method, the details of which were described in our previous publications (2-4). The heparinized blood obtained from other large dogs under slight thiopental anesthesia (20 mg/kg, i.v.) was used for priming of the extracorporeal circuit. Coronary sinus outflow was led out by a Morawitz cannula, measured with a square-wave electromagnetic flow meter (Nihon Kohden MF26) with a can nulating-type flow probe (2 mm internal diameter) and returned to the preparation via the inferior vena cava. The total coronary blood flow was calculated as 10/6 of the coronary sinus outflow (5). Chemical sympathectomy of the animals was conducted by injecting 6-OH dopamine intravenously in increasing doses every other day for 5 days, until the cumulative dose reached around 70 mg/kg. To avoid the acute toxicity of the substance, it was administered as two divided doses (1st day: 2+3, 3rd day: 5+15, 5th day: 15+30 mg/kg). 6-OH dopamine was dissolved in ascorbic acid. To check the completeness of the chemical denervation, tyramine was injected to the preparation up to the dose of 1 mg. No positive inotropic and chronotropic effect was observed.
For analysis of the 6-keto PGF1a, blood samples were collected from the arterial side of the preparation into chilled test tubes and were centrifuged within 5 min to separate the plasma. The plasma was kept frozen at -80°C until further processing . 6-Keto PGF1a was quantitated by GC-MS after extraction and purification with thin-layer chromato graphy as described by Miyazaki et al. (6) .
As shown in Fig. 1 The upper half of Fig. 2 summarizes the data on CBF, 6-keto PGF1a in the circulating blood and the magnitude of vasodilator response to PG 12 at the start of the experi ments. The lower half illustrates the rate of increase in CBF and 6-keto PGF1a at the stage of linear increase in these two para meters. As stated above, the initial CBF tended to be a little higher and the vasodilator response to PG 12 at the start of the experi ments was significantly larger (P<0.01) in the chemically denervated HLP. The level of 6-keto PGF1a in the circulating blood at the start of the experiments was significantly lower (P<O.O1) in the denervated HLP.
The rate of CBF increase inherent in HLP was found to be significantly larger (P<0.05) in denervated HLP than in innervated HLP as shown in this figure. Though a little higher in denervated HLP, the rate of increase in 6-keto PGF1a in the circulating blood was not significantly different from that in the non-treated HLP. in HLP was due not to the enhanced production of PGI2, but to the enhanced reactivity of the coronary blood vessels to PG12. The fact that the initial level of 6-keto PG F1 a was lower i n the denervated HLP indicates that the sympathetic nervous system exerted a tonic accelerating influence on PG12 production in HLP at least at the initial stage. Enhanced vasodilator responsiveness of the coronary blood vessel to exogenous PG 12 observed i n denervated H LPs at the start of the experiments is compatible with the idea of tonic accelerating influence of the sympathetic nervous system on PG12 pro duction, for it may be explained by the lesser preoccupancy of PG12 receptor by endoge nous PG12 in sympathetically denervated HLP. Increased release of PGs by nerve stimulation and catecholamines readily occurs in a number of adrenergically innervated tissues including the heart (7) (for further references, see Hedqvist (8)). In most cases, the PG predominantly released is PG E2 followed by PG Fla. However, a recent report by Wennmalrrn (9) indicated that PG12 was also released from the heart under these conditions.
The initial level of CBF was not reduced despite a significantly lower level of 6-keto PG F10. This may also be explained by the enhanced responsiveness to PG12.
